| Model Number |
8834369001 |
| Medical Device Problem Codes |
Break (1069); Product Quality Problem (1506)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
02/06/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
According to the reporter, during use, the catheter was corrupted in the patients pleura region.There was leak in the intra pleural.Chlorhexidine was used as a cleaning agent.A medical intervention was done to relocate the catheter and implant another.The patient extended their hospitalization.
|
| |
|
Event or Problem Description
|
|
According to the reporter, during use, the catheter was corrupted in the patients pleura region.There was a leak in the intra pleura.It was stated that the insertion site was via intra-atrial thoracotomy.Chlorhexidine was used as a cleaning agent.A medical intervention was done to relocate the catheter and implant another and patient was injected with electrolyte solution.The hemodialysis treatment was delayed.The patient hospitalization was extended.
|
| |
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Evaluation summary: post market vigilance (pmv) led a photographic evaluation of one device.Visual inspection and functional testing confirmed there were no abnormalities that would have caused or contributed to the reported condition.Records from each manufacturing lot are thoroughly reviewed to ensure that products are released meeting all quality release specifications at the time of manufacture.The investigation concluded there were no abnormalities that would have caused or contributed to the reported condition.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
According to the reporter, during use, the catheter was corrupted/broke in the patients pleura region.There was a leak in the intra pleura.It was stated that the insertion site was via intra-atrial thoracotomy.Chlorhexidine was used as a cleaning agent.A medical intervention was done to relocate the catheter and implant another and patient was injected with electrolyte solution.The catheter was replaced.The hemodialysis treatment was delayed.The patient hospitalization was extended.There was no reported patient injury.
|
| |
|
Search Alerts/Recalls
|